Estazolam
Pronunciation: es-TAY-zoh-lam.
- Generic name
- estazolam
- Brand names
- ProSom (United States and Canada -- both discontinued; generic estazolam remains marketed in the US), Nuctalon (France/EU)
- Drug class
- Benzodiazepine (triazolobenzodiazepine sedative-hypnotic)
- Form
- Tablet, 1 mg or 2 mg (US); 2 mg (France, Nuctalon)
- Route
- Oral
- Legal status
- Prescription-only, controlled substance where authorised (Schedule IV in the US federal Controlled Substances Act); separately a controlled/scheduled substance in the UK and Australia even though it is not licensed as a medicine in either country.
Availability and supply rules vary by country
Trade names by country: United States · United Kingdom · Canada · Australia · New Zealand
Australia: None -- not registered for therapeutic use in Australia (5) · Full directory
Boxed warning: Risks from concomitant use with opioids; and risks of abuse, misuse, addiction, physical dependence, and life-threatening withdrawal reactions
Estazolam carries a boxed warning (the US FDA's strongest safety warning), added to all benzodiazepine labels, with three distinct parts. First: concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death; reserve concomitant prescribing for patients with no adequate alternative treatment options, and limit dosages and durations to the minimum required. Second: the use of benzodiazepines, including estazolam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death; abuse and misuse commonly involve concomitant use of other medicines, alcohol, and/or illicit substances, which increases the risk of serious harm. Third: continued use of estazolam may lead to clinically significant physical dependence; abrupt discontinuation or a rapid dose reduction, or administration of flumazenil (a benzodiazepine antagonist) to a physically dependent patient, may precipitate acute withdrawal reactions, including seizures, which can be life-threatening. Because of these genuine risks, estazolam dose changes, tapering, and stopping must always be planned and supervised by your prescriber, never carried out on your own. (1)
What estazolam is and how it works
Estazolam is a prescription benzodiazepine medicine used for the short-term treatment of insomnia (trouble falling asleep, waking during the night, or waking too early). It was originally sold as ProSom in the US and Canada, but that brand has been discontinued in both countries; it is currently available as a generic medicine in the United States and as Nuctalon in France. (1)
Estazolam carries a genuine, current boxed warning -- the FDA's strongest safety warning -- covering three real risks: dangerous, potentially fatal breathing problems if combined with opioids; risk of abuse, misuse, and addiction; and risk of physical dependence with life-threatening withdrawal reactions if stopped abruptly or the dose is reduced too quickly. Because of these risks, estazolam is intended for short-term use (evidence supports up to 12 weeks), and any change in dose or plan to stop must always be made together with your prescriber -- never on your own.
Mechanism of action: how estazolam works
Estazolam is a triazolobenzodiazepine CNS depressant. It is extensively metabolised via CYP3A to 4-hydroxy-estazolam (the major metabolite) and other metabolites, with an elimination half-life of about 10-24 hours (mean approximately 18.4 hours in elderly patients), and is primarily excreted renally. (1)
What estazolam is used for
Short-term management of insomnia
Used for the short-term treatment of insomnia characterised by difficulty falling asleep, waking during the night, and/or waking too early. Evidence supports effectiveness for up to 12 weeks; prolonged use is generally neither necessary nor recommended. (1) (3)
Before taking estazolam
Do not take / not appropriate for
- Do not take estazolam if you have had a hypersensitivity (allergic) reaction to estazolam or any other benzodiazepine. (all countries where authorised) (1)
- Do not take estazolam together with ketoconazole or itraconazole (strong interactions that significantly raise estazolam levels). (United States) (1)
Tell your clinician about
- Whether you are pregnant, planning to become pregnant, or breastfeeding.
- Any history of depression or suicidal thoughts.
- Any history of substance use disorder, or alcohol use.
- Any breathing problems, including sleep apnoea.
- All other medicines you take, especially opioids, other sedatives, antifungal medicines (ketoconazole, itraconazole), and other medicines that affect CYP3A liver enzymes.
- Whether you have ever had a serious allergic reaction (angioedema) to estazolam or another benzodiazepine.
- Whether you smoke, since smoking can change how quickly your body clears this medicine.
How to take estazolam
- Take estazolam exactly as your prescriber directs, usually at bedtime.
- Only take estazolam if you are able to get a full night's sleep before you need to be active again.
- Do not stop taking estazolam or change your dose without talking to your prescriber -- if you and your prescriber decide to stop, this is normally done with a gradual, prescriber-supervised taper, not all at once, because of the real risk of withdrawal.
- Tell your prescriber right away if you experience 'sleep-driving' or other activities (such as preparing food, making phone calls, or having sex) that you do not remember doing -- this is a genuine, recognised risk, especially if combined with alcohol or other sedating medicines.
- Avoid alcohol while taking estazolam, and avoid activities requiring full mental alertness, such as driving, until you know how the medicine affects you.
Procedures and treatment changes
Tell the treating team before surgery, procedures, or any medicine change. Do not alter treatment without the responsible clinician. (1) (2) (3) (4) (5) (6)
Missed dose
Estazolam is taken as needed at bedtime for sleep, not on a fixed daily schedule in the same way as most medicines -- only take it when you are able to get a full night's sleep. If you have questions about your specific dosing schedule, ask your pharmacist or prescriber.
Overdose
Seek emergency medical attention immediately if too much estazolam has been taken, especially if combined with alcohol or other sedating medicines, which can be fatal. Symptoms can range from drowsiness and confusion to coma. There is a reversal medicine (flumazenil) that a medical team can consider, but it carries its own risks, including seizures, particularly after long-term benzodiazepine use. (1)
Side effects
Side effects and their urgency vary; report severe, persistent, or concerning symptoms.
Sleepiness (somnolence) the next day.
What to notice: Sleepiness (somnolence) the next day.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)
Headache.
What to notice: Headache.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)
Weakness (asthenia) or reduced movement (hypokinesia).
What to notice: Weakness (asthenia) or reduced movement (hypokinesia).
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)
Dizziness or problems with coordination.
What to notice: Dizziness or problems with coordination.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)
Nausea.
What to notice: Nausea.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)
Serious warnings
Dangerous breathing problems with opioids — boxed_warning
Symptoms: Severe drowsiness, slow or shallow breathing, or unresponsiveness.
Action: Seek emergency help immediately. Never combine estazolam with opioids (such as prescription painkillers) unless your prescriber has specifically told you to, and only under close medical supervision. (1)
Abuse, misuse, and addiction — boxed_warning
Symptoms: Using more than prescribed, using it for its effects rather than for sleep, or feeling unable to control your use.
Action: Tell your prescriber if you are worried about your use of this medicine, or if you have a personal or family history of substance use problems -- your prescriber can discuss safer alternatives or additional support. (1)
Physical dependence and life-threatening withdrawal — boxed_warning
Symptoms: Anxiety, tremor, sweating, insomnia, or in severe cases, seizures, if the medicine is stopped abruptly or the dose reduced too quickly after regular use.
Action: Never stop or reduce your dose on your own. Your prescriber will supervise a gradual taper if you need to stop, because abrupt discontinuation can trigger a genuinely life-threatening withdrawal reaction. (1)
Sleep-driving and other complex sleep behaviours — high caution
Symptoms: Driving, preparing and eating food, making phone calls, or having sex while not fully awake, with no memory of the event afterward.
Action: Contact your prescriber promptly if this happens -- discontinuation is strongly recommended, especially if it occurs alongside alcohol or other sedating medicines. (1)
Serious allergic reaction (angioedema) — emergency
Symptoms: Swelling of the tongue, throat, or voice box, sometimes with difficulty breathing.
Action: Seek emergency medical help immediately -- this rare reaction can cause airway obstruction and can be fatal; estazolam should never be restarted after this occurs. (1)
Worsening depression or suicidal thoughts — high caution
Symptoms: New or worsening low mood, hopelessness, or thoughts of self-harm.
Action: Contact your prescriber promptly, or seek emergency help if you have thoughts of harming yourself -- estazolam should be used with caution in people showing signs of depression. (1)
Falls, especially in older adults — high caution
Symptoms: Drowsiness, unsteadiness, or reduced alertness.
Action: Take extra care with balance and mobility, particularly if you are older -- tell your prescriber if you feel unsteady, since your dose may need adjusting. (1)
Interactions
- Opioid pain medicines significantly increase the risk of profound sedation, breathing problems, and death when combined with estazolam. (1)
- Ketoconazole and itraconazole (antifungal medicines) significantly raise estazolam levels and should not be combined with it. (1)
- Other CYP3A-affecting medicines -- such as nefazodone, fluvoxamine, cimetidine, diltiazem, isoniazid, and macrolide antibiotics -- can raise estazolam levels and should be used cautiously together. (1)
- Alcohol, other sedatives, anticonvulsants, antihistamines, and other psychotropic medicines can increase drowsiness and sedation when combined with estazolam. (1)
- Smoking can speed up how quickly estazolam is cleared from the body, potentially reducing its effect. (1)
Pregnancy, breastfeeding, kidney/liver function, age
Pregnancy
Estazolam has not been shown to be clearly associated with major birth defects in observational studies, but benzodiazepines cross the placenta, and use late in pregnancy can cause sedation, breathing problems, floppiness, or withdrawal signs in the newborn. A pregnancy exposure registry exists in the US. Discuss the risks and benefits with your prescriber if you are pregnant or planning a pregnancy. (1) (2) (3) (4) (5) (6)
Breastfeeding
Breastfeeding is not recommended while taking estazolam, because of its long duration of action, the possibility of build-up in the baby, and reports of infant sedation, poor feeding, and poor weight gain. (1) (2) (3) (4) (5) (6)
Children
Safety and effectiveness have not been established in people under 18 years of age. (1) (2) (3) (4) (5) (6)
Elderly
Older adults are usually started on a lower dose, since they may be more sensitive to sedation and at higher risk of falls; small or frail elderly patients may start at an even lower dose. (1) (2) (3) (4) (5) (6)
Hepatic_impairment
Specific dosing guidance for liver impairment was not detailed in the sources reviewed for this dossier; discuss with your prescriber if you have liver disease. (1) (2) (3) (4) (5) (6)
Renal_impairment
Specific dosing guidance for kidney impairment was not detailed in the sources reviewed for this dossier; discuss with your prescriber if you have kidney disease. (1) (2) (3) (4) (5) (6)
Source_ids
Monitoring
Before starting
- Review of other medicines, especially opioids and antifungal medicines
- Assessment of substance-use and mental-health history
- Discussion of realistic treatment duration (short-term use)
During treatment
- Regular review of whether continued use is still needed, since estazolam is intended for short-term use.
- Watching for signs of sleep-driving or other complex sleep behaviours.
- Watching for signs of low mood or suicidal thoughts.
- Any planned dose reduction or stopping done gradually and under prescriber supervision.
Storage
Store at controlled room temperature, 20-25degC (68-77degF), in a tight, light-resistant container, out of reach of children and anyone for whom it was not prescribed.
Study the drug class: Benzodiazepines
Professional information
Clinician-facing context only, sourced from the current (revised June 2024) US FDA/DailyMed generic estazolam prescribing information; verify against the current full local label before prescribing. Note the genuinely mixed international authorisation picture -- estazolam is not authorised in every market.
United States
Indication: Short-term management of insomnia
Dose summary: Initial 1 mg at bedtime; some patients require 2 mg. Elderly: initial 1 mg; small/debilitated patients may start at 0.5 mg with careful titration.
Renal context: Not separately studied/detailed in the reviewed label; use caution and consider lower doses in renal impairment. (1)
Hepatic guidance
Not separately studied/detailed in the reviewed label.
Overdose note
CNS depression ranging from drowsiness to coma; combined overdose with other CNS depressants (alcohol, opioids) may be fatal. Flumazenil can reverse sedation but carries a withdrawal/seizure risk, particularly with mixed overdose or chronic benzodiazepine use, and is contraindicated if the benzodiazepine was used to treat a life-threatening condition such as status epilepticus. (1)
Frequently asked questions
Does estazolam have a boxed warning?
Yes. Estazolam's current US FDA label carries the class-wide benzodiazepine boxed warning: dangerous, potentially fatal breathing problems if combined with opioids; risk of abuse, misuse, and addiction; and risk of physical dependence with life-threatening withdrawal reactions if stopped abruptly. Never change your dose or stop without talking to your prescriber. (1)
Is estazolam available everywhere?
No. Estazolam is currently available as a generic medicine in the United States and as Nuctalon in France. It was previously sold in Canada as ProSom, but that product's authorisation was cancelled in 1997 and it is not currently available there. It is not licensed as a medicine in the United Kingdom or registered for therapeutic use in Australia, even though both countries separately classify it as a controlled substance. (1) (4) (2) (5)
What happened to ProSom?
ProSom was the original brand name for estazolam in the United States and Canada. It has been discontinued in both countries -- in the US, generic estazolam remains available; in Canada, the product's market authorisation was cancelled in 1997 and no version is currently available. (4)
What is the mechanism of action of estazolam?
Estazolam is a triazolobenzodiazepine CNS depressant. It is extensively metabolised via CYP3A to 4-hydroxy-estazolam (the major metabolite) and other metabolites, with an elimination half-life of about 10-24 hours (mean approximately 18.4 hours in elderly patients), and is primarily excreted renally. (1)
References
- ESTAZOLAM tablet, USP (C-IV) -- full prescribing informationU.S. Food and Drug Administration / DailyMed (NIH), full prescribing information (generic estazolam, Teva/Watson, ANDA 074818) · United States · accessed 2026-07-30 · source 1
- ACMD review of novel benzodiazepines -- estazolam listed among benzodiazepines not licensed as medicines in the UK, separately controlled as Class CUK Advisory Council on the Misuse of Drugs (ACMD), a statutory UK government advisory body, plus general web-search corroboration · United Kingdom · accessed 2026-07-30 · source 2
- NUCTALON (estazolam) -- HAS opinion (renewal of registration/reassessment, 25 June 2014) and French drug-reference listingsHaute Autorite de Sante (HAS), France -- Transparency Committee opinion, plus VIDAL/Sante.fr French drug-reference corroboration · European Union (France) · accessed 2026-07-30 · source 3
- PROSOM (estazolam) 2 mg tablet -- Drug Product Database entry, status Cancelled Post MarketHealth Canada Drug Product Database · Canada · accessed 2026-07-30 · source 4
- Estazolam -- Office of Drug Control controlled-substances listing; not registered for therapeutic use in AustraliaAustralian Government Office of Drug Control (ODC), plus TGA ARTG search corroboration · Australia · accessed 2026-07-30 · source 5
- No Medsafe New Zealand Data Sheet located for estazolamMedsafe, New Zealand -- absence of a located Data Sheet · New Zealand · accessed 2026-07-30 · source 6
Brand names by country
Single-ingredient estazolam names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.
Priority countries
United States
- Generic estazolam (brand ProSom discontinued) (1)FDA approved currently labeled generic only · 1 mg, 2 mg · Teva Pharmaceuticals (manufactured by Watson Pharma)
United Kingdom
- None -- not licensed as a medicine in the UK (2)not licensed medically controlled class C only · not applicable
Canada
- ProSom (cancelled post-market 1997) (4)Health Canada cancelled post market · 2 mg · Historical: Abbott Laboratories Limited
Australia
- None -- not registered for therapeutic use in Australia (5)not registered ODC controlled substance only · not applicable
New Zealand
- No Medsafe data sheet located (6)unable to verify no listing found · not applicable
View brands in additional countries.
European Union
Nuctalon (France) (3)